These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 5991934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [New therapeutic technic in diseases of the efferent bile ducts].
    Dierel H.
    Wien Med Wochenschr; 1972 Apr 01; 122(14):187-90. PubMed ID: 5014036
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM, Barkhanova AG, Zakharova GIu.
    Klin Med (Mosk); 1989 Sep 01; 67(9):129-35. PubMed ID: 2685457
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Studies on the potency of action of several choleretics].
    Mörsdorf K, Wolf G.
    Dtsch Med J; 1966 May 31; 17(10):303-6. PubMed ID: 5985421
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical experience with the amphocholeretic drug Odibil in primary and secondary organic as well as functional cholecysto- and cholangiohepathopathies].
    Hunold W.
    Z Allgemeinmed; 1975 Feb 20; 51(5):237-41. PubMed ID: 1093341
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pharmacotherapy of chronic cholecystitis].
    Tsimmerman IaS.
    Sov Med; 1987 Feb 20; (4):53-6. PubMed ID: 3603188
    [No Abstract] [Full Text] [Related]

  • 14. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
    Cremoncini C, Tominz L.
    Minerva Med; 1968 Oct 13; 59(82):4359-68. PubMed ID: 5683717
    [No Abstract] [Full Text] [Related]

  • 15. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V.
    Vutr Boles; 1973 Oct 13; 12(2):69-73. PubMed ID: 4713058
    [No Abstract] [Full Text] [Related]

  • 16. [The chologenic and choleretic action of sorbitol].
    Grancharov V.
    Vopr Pitan; 1973 Oct 13; 32(2):50-4. PubMed ID: 4782923
    [No Abstract] [Full Text] [Related]

  • 17. [On treatment of biliary infections with Amplital].
    Andolfatto Zaglia G, Roberti G.
    Minerva Med; 1965 Sep 12; 56(73 Suppl):3107-8. PubMed ID: 5320334
    [No Abstract] [Full Text] [Related]

  • 18. The postcholecystectomy syndromes.
    Bodvall B.
    Clin Gastroenterol; 1973 Jan 12; 2(1):103-26. PubMed ID: 4588233
    [No Abstract] [Full Text] [Related]

  • 19. [Cholelithin therapy of angiocholecystites and dyskinesias of bile ducts in children].
    Shmorgun SS, Cherniavskaia VG.
    Pediatr Akus Ginekol; 1967 Jan 12; 2():27-9. PubMed ID: 5610524
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical and experimental study of danfukang granule in treating cholecystitis and cholelithiasis].
    Niu SK, Wang JT, Li ZZ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 May 12; 16(5):277-9. PubMed ID: 9387718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.